News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,441 Results
Type
Article (39425)
Company Profile (306)
Press Release (648710)
Section
Business (204785)
Career Advice (2004)
Deals (35476)
Drug Delivery (87)
Drug Development (80993)
Employer Resources (168)
FDA (16117)
Job Trends (14860)
News (345811)
Policy (32547)
Tag
Academia (2548)
Alliances (49431)
Alzheimer's disease (1235)
Approvals (16048)
Artificial intelligence (130)
Bankruptcy (354)
Best Places to Work (11556)
Biotechnology (217)
Breast cancer (121)
Cancer (1083)
Cardiovascular disease (97)
Career advice (1672)
Cell therapy (234)
Clinical research (64362)
Collaboration (389)
Compensation (197)
COVID-19 (2546)
C-suite (95)
Data (1120)
Diabetes (153)
Diagnostics (6159)
Earnings (84945)
Employer resources (146)
Events (109976)
Executive appointments (310)
FDA (16654)
Funding (352)
Gene therapy (177)
GLP-1 (579)
Government (4339)
Healthcare (18689)
Infectious disease (2631)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16330)
Job creations (3659)
Job search strategy (1429)
Layoffs (417)
Legal (7888)
Lung cancer (170)
Manufacturing (177)
Medical device (13185)
Medtech (13190)
Mergers & acquisitions (19219)
Metabolic disorders (403)
Neuroscience (1512)
NextGen Class of 2024 (6534)
Non-profit (4476)
Northern California (1479)
Obesity (231)
Opinion (183)
Patents (102)
People (56594)
Phase I (20009)
Phase II (28360)
Phase III (21126)
Pipeline (455)
Postmarket research (2554)
Preclinical (8523)
Radiopharmaceuticals (236)
Rare diseases (218)
Real estate (5936)
Regulatory (21583)
Research institute (2316)
Resumes & cover letters (350)
Southern California (1304)
Startups (3614)
United States (13495)
Vaccines (550)
Weight loss (168)
Date
Today (133)
Last 7 days (777)
Last 30 days (3788)
Last 365 days (35746)
2024 (32789)
2023 (40177)
2022 (51288)
2021 (55836)
2020 (54157)
2019 (46644)
2018 (35124)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26501)
2012 (28771)
2011 (29428)
2010 (27530)
Location
Africa (716)
Arizona (192)
Asia (37328)
Australia (6105)
California (3337)
Canada (1290)
China (248)
Colorado (145)
Connecticut (152)
Europe (80003)
Florida (458)
Georgia (116)
Illinois (344)
Indiana (197)
Kansas (97)
Maryland (576)
Massachusetts (2612)
Michigan (157)
Minnesota (272)
New Jersey (952)
New York (958)
North Carolina (702)
Northern California (1479)
Ohio (141)
Pennsylvania (845)
South America (1094)
Southern California (1304)
Texas (464)
Utah (90)
Washington State (361)
688,441 Results for "avance biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
Axogen, Inc. is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft ® on May 15, 2024.
May 16, 2024
·
7 min read
Drug Development
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
Oragenics, Inc., a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, announced a partnership with Avance Clinical, a leading Contract Research Organization, to conduct a Phase II clinical trial in Australia.
May 7, 2024
·
4 min read
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS
June 3, 2024
·
3 min read
Press Releases
Avance Clinical Announces Senior Appointment to North American Operations
July 31, 2024
·
4 min read
Press Releases
Avance Clinical Joins the Australian Clinical Trials Roadshow, Sharing Cost and Time Benefits for Early-Phase US Biotechs
September 13, 2024
·
4 min read
Press Releases
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
September 6, 2024
·
6 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
6 min read
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
Axogen, Inc. today announced the successful first week of processing for Avance Nerve Graft at the newly opened Axogen Processing Center (APC), in Dayton, Ohio.
August 21, 2023
·
6 min read
Press Releases
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
·
4 min read
1 of 68,845
Next
